Systematic review of pregnancy safety data for small molecules used in the treatment of inflammatory bowel disease

Clinicians and researchers from the Leeds Gastroenterology Institute (UK) have published a systematic review which has identified preliminary safety data for tofacitinib, filgotinib, upadacitininb, and ozanimod, small molecules used in the treatment of inflammatory bowel disease. More information is available here.